Litigation in Generic Markets: How Patent Disputes Delay Affordable Medicines
Patent litigation in generic drug markets is delaying affordable medicines by exploiting loopholes in the Hatch-Waxman Act. Improper Orange Book listings, serial lawsuits, and pay-for-delay settlements are keeping prices high and patients waiting years beyond patent expiration.
11 Dec 2025